Search

Displaying results 181 - 190 of 705 in total
  1. Drug

    2-ethylhexyl benzoate

    go.drugbank.com/drugs/DB11291
    ApprovedWithdrawn

    Mixtures: UV Capture Vita Sun Gel
  2. Drug

    NADH

    go.drugbank.com/drugs/DB00157
    ApprovedNutraceutical

    NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH, a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved i...

    Mixtures: Genicin Vita-Q
  3. Drug

    Streptococcus thermophilus

    go.drugbank.com/drugs/DB16548
    ApprovedInvestigationalWithdrawn

    Mixtures: Risa-Bid Caplet
  4. Drug

    Marzeptacog alfa (activated)

    go.drugbank.com/drugs/DB15278
    Investigational

    Marzeptacog alfa (activated) is under investigation in clinical trial NCT01439971 (Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects

  5. Drug

    Butoconazole

    go.drugbank.com/drugs/DB00639
    Approved

    Butoconazole is an imidazole antifungal used in gynecology.

  6. Drug

    Cefpiramide

    go.drugbank.com/drugs/DB00430
    Approved

    Cefpiramide is a third-generation cephalosporin antibiotic.

  7. Drug

    Droxicam

    go.drugbank.com/drugs/DB09215
    ApprovedWithdrawn

    Droxicam is an oxicam non-steroidal anti-inflammatory drug and a prodrug of DB00554. It is used to reduce pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis.

  8. Drug

    Lactobacillus delbrueckii bulgaricus

    go.drugbank.com/drugs/DB16540
    ApprovedInvestigationalWithdrawn

    Mixtures: Risa-Bid Caplet
  9. Drug

    Oxyphenonium

    go.drugbank.com/drugs/DB00219
    Approved

    A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of atropine. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used i...

  10. Drug

    Cilgavimab

    go.drugbank.com/drugs/DB16393
    ApprovedInvestigational

    SARS-CoV-2, the causative agent of COVID-19, enters cells via the interaction between the trimeric spike (S) glycoprotein and host cell angiotensin-converting enzyme 2 (ACE2).